Helping those who need it most at Amicus Therapeutics

Nothing can be more devastating that the diagnosis of an unexpected health condition. In particular, a health condition or disease that is not well understood or well known to Health care providers. This can leave a person feeling vulnerable and helpless. Luckily, there are Organizations out there whose sole mission is to help those in need when they need it the most. Follow Amicus Therapeutics on Twitter.

At Amicus Therapeutics, it is our passion that drives us to find solutions where solutions don’t currently exist. We strive to obsolete our own technologies, encourage and embrace constant innovation, take smart risks, push ideas as far and as fast as possible and most importantly, think very differently from others. These core values are what give Amicus Therapeutics an edge and allow us to remain at the forefront of therapies for rare and orphan diseases.

Amicus Therapeutics is constantly driving to deliver new therapies for those in need, when they need it the most. There are several products late into the development and regulatory phase which will provide treatments for a range of human genetic diseases. This includes Migalastat, a cutting edge medicine intended to treat those with Fabry disease. SD-101, another product late in the development stage would be one of the earliest, if not the first, therapy available to those who have been diagnosed with Epidermolysis Bullosa (EB).


Amicus Therapeutics has the luxury of utilizing our platform biologics and Chaperone-Advanced Replacement Therapy (CHART™) to develop multiple new enzyme replacement therapy (ERT) products that will help those suffering from a myriad of rare diseases such as Fabry disease, Pompe disease, and other Lysosomal Storage Disorders (LSDs).

Amicus Therapeutics has Corporate Head Quarters in Cranbury, NJ and has several locations across the globe. While we are a company that is spread across the globe, our goals of innovating solutions to patients most in need remain united.

The fight will never stop and hope will always remain for patients suffering from rare and orphan diseases. Amicus Therapeutics is there for you. Read more at about Amicus Therapeutics.

Leave a Reply

Your email address will not be published. Required fields are marked *